Intravitreal triamcinolone for cystoid macular edema related to branch retinal vein occlusion.
We retrospectively evaluated the effectiveness of intravitreal triamcinolone in treating 19 eyes with macular edema related to branch retinal vein occlusion (BRVO). Eyes with nonischemic BRVO respond more favorably than those with ischemic BRVO. A single injection of intravitreal triamcinolone led to elevated intraocular pressure in 3 of 19 eyes (16%). Half of phakic eyes had progression of cataract. Retreatment may be necessary.
Bearelly
Srilaxmi
S
Albert Eye Research Institute, Duke University Eye Center, Department of Ophthalmology, Durham, NC 27710, USA. beare002@mc.duke.edu
Cooney
Michael J
MJ
Stinnett
Sandra
S
Fekrat
Sharon
S
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012170:Retinal Vein Occlusion / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D012189:Retrospective Studies; D014221:Triamcinolone / Q000008:administration & dosage*; D014822:Vitreous Body / Q000187:drug effects* / Q000502:physiology
D014221:Triamcinolone